QUETIAPINE FUMARATE | N022047 | CHEPLAPHARM ARZNEIMITTEL GMBH
| Case | Court | Filed | Status | Judge |
|---|---|---|---|---|
ASTRAZENECA PHARMACEUTICALS LP et al v. AMNEAL PHARMACEUTICALS, LLC et al 1 patentANDA 204112quetiapine fumarate | D.N.J. | 2012-08-02 | Terminated 2013-01-15 | — |
Source: PACER. NOS 835 (Patent - Abbreviated New Drug Application).
| Petition | Type | Filed | Status | Petitioner |
|---|---|---|---|---|
AstraZeneca Pharmaceuticals LP - Citizen Petition FDA-2011-P-0663 · 3 docket documents AstraZeneca Pharmaceuticals LP filed this citizen petition under section 505(j) of the Federal Food, Drug, and Cosmetic Act requesting that the FDA not approve any quetiapine abbreviated new drug application (ANDA) with Seroquel XR as the reference listed drug if the proposed labeling omits informat | 505(q) | 2011-09-20 | Denied | — |
Lachman Consultant Services, Inc - Citizen Petition FDA-2007-P-0011 · 6 docket documents Lachman Consultant Services, Inc. filed this citizen petition requesting that the FDA determine whether AstraZeneca Pharmaceuticals LP voluntarily withdrew Seroquel (quetiapine fumarate) 150 mg tablets, approved under NDA 20-639, for safety or effectiveness reasons, or whether the discontinuation wa | 505(q) | 2008-04-10 | Granted | — |
Source: Regulations.gov. FDA citizen petitions matched by application number.
No patent or exclusivity listings for this strength.